Article
Preclinical modeling of myelodysplastic syndromes
2 Jun 2017
Abstract excerpt
Myelodysplastic syndromes (MDS) represent a heterogeneous group of hematological clonal disorders. Here, we have tested the bone marrow (BM) cells from 38 MDS patients covering all risk groups in two immunodeficient mouse models: NSG and NSG-S. Our data show comparable level of engraftment in both models. The level of engraftment was patient specific with no correlation to any specific MDS risk group....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
